Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple decision tree could help stroke patients get faster care for muscle stiffness

NCT ID NCT06381999

Knowledge-focused Sponsor: Merz Therapeutics GmbH Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed study tested whether a simple decision tree tool can help nurses and physical therapists recognize early signs of spasticity (muscle stiffness) in people who have had a stroke. Researchers compared the tool's accuracy against assessments by specialized doctors. The study involved 70 participants and aimed to see if non-specialists could reliably identify patients who need a referral for treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the tool works well, it could help nurses and therapists catch spasticity earlier after a stroke, leading to faster referrals and better care.
What could go wrong
This is a small, completed study focused on testing the tool's accuracy, not on patient outcomes. The tool may not work as well in real-world settings or for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

70 people

The number who actually took part.

Started

Oct 2023

Finished

Feb 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study participants are post-stroke survivors and patients of the Gailtal Clinic in Hermagor. Participants were either sub-acute in-patients as part of the post-stroke rehabilitation program or chronic out-patients. Participants are recruited using consecutive participant sampling. All sub-acute patients in the rehabilitation ward who fulfill inclusion criteria and agree to participate are enrolled. Additionally, chronic patients scheduled for botulinum toxin injections on the study day are also enrolled in the study.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants with a first sub-acute and chronic infarction of the middle cerebral artery / basal ganglia hemorrhage longer than four weeks after the event * Between 18-80 years old * Preserved insight and judgment capacity * Adequate language and task comprehension, attention span for 15 minutes Exclusion Criteria: * Participants with other neurological disorders * Participants who received BoNT-A treatment \< 3 months before inclusion * Reduced vigilance and attention span (less than 15 minutes) * Participants with adult representation * Participants with severe language impairment / impairment of movement and action sequences

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-stroke spasticity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post-stroke spasticity

Contacts and locations

Locations

  • Gailtal-Klinik

    Hermagor, 9620, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.